Monday, March 25, 2024 2:30:43 PM
"We are thrilled to announce these outstanding financial achievements for the fiscal year 2023," said Norman Tipton, CEO of Trucept Inc. "Our relentless dedication to enhancing financial stability, operational efficiency, and sustainable growth has yielded exceptional results. We remain committed to delivering value to our stakeholders while maintaining a strong financial foundation."
Highlights include:
Successful Accounts Receivable Collection Efforts: Trucept focused its Accounts Receivable collection efforts in 2023, resulting in a substantial reduction in its AR balance by $4,118,457. This concerted effort underscores Trucept's commitment to financial stability and efficient operations.
Impressive Increase in Working Capital: Trucept accomplished a remarkable 111% increase in Working Capital during 2023. The increase of $1,063,214 brought Trucept's working capital ratio into positive territory. This achievement directly correlates with the successful cash collection efforts mentioned earlier, and reflects Trucept's sound financial management practices.
Sustained Operational Efficiencies and Corporate Growth: While focusing on corporate growth initiatives, Trucept also maintained its operational efficiencies throughout 2023. This is evidenced by the remarkable 44% year-over-year increase in "Profit from Operations" and the notable improvement in Net Profit Percentage from 8% in 2022 to 9% in 2023. These results underscore Trucept's ability to balance growth with operational excellence.
Trucept Inc. continues to innovate and adapt to meet the evolving needs of its clients while driving sustainable growth and delivering shareholder value. It's portfolio of professional services includes:
Data Driven Marketing, Technology, and Accessibility Act compliance
Insurance Offerings and Third-party Administrator (TPA) services
Full-Service Payroll
Human Resources and Management
Accounting Support
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM